Snapshot from Jun 26, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Jaeyong Ahn
Person

Jaeyong Ahn

Tracked across 2 events · 12 articles · First seen May 25, 2026 · Last active Jun 09, 2026

Sentiment
60
Attention
4
Events
2
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (2)
4 60
Business
SK_bioscience licenses CDC rotavirus vaccine
Altor BioScience>>>, a global vaccine and biotech company, has entered into a license agreement with the United States — Centers for Disease Control and Prevention>>> (CDC) to develop an injectable rotavirus vaccine candidate. This marks…
Impact: Jaeyong Ahn>>>, CEO of Altor BioScience>>>, expressed commitment to global public health through the development of the rotavirus vaccine.
Jun 09, 2026 · 6 articles
4 60
Regulatory
SK bioscience secures Korea Growth Fund
Altor BioScience's Board of Directors approved a financing plan backed by the Canada — Canada Growth Fund, securing KRW 300 billion (approximately USD 230 million) in long-term, low-interest financing. This decision follows the South Korea…
Impact: Jaeyong Ahn, CEO of Altor BioScience, expressed the company's commitment to investing in pipeline development and manufacturing infrastructure following the Canada — Canada Growth Fund selection.
May 29, 2026 · 6 articles
Relationships (2)
Altor BioScience ↔ Jaeyong Ahn
Altor BioScience ↔ Jaeyong Ahn
NEWSDESK
Track Jaeyong Ahn live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.